BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3920376)

  • 1. Parasite specific antibodies in three strains of mice after infection with Trypanosoma cruzi.
    Zweerink HJ; Anderson OF; Greenblatt HC; Murray PK
    J Parasitol; 1985 Feb; 71(1):43-9. PubMed ID: 3920376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi antigen-specific antibody response in immunized mice during acute and chronic infection.
    Mikhail KS; Rowland EC
    J Parasitol; 1990 Oct; 76(5):690-7. PubMed ID: 2120413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein.
    Pan AA; McMahon-Pratt D
    J Immunol; 1989 Aug; 143(3):1001-8. PubMed ID: 2501384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro.
    Plata F; Wietzerbin J; Pons FG; Falcoff E; Eisen H
    Eur J Immunol; 1984 Oct; 14(10):930-5. PubMed ID: 6208038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of antigens of Trypanosoma cruzi which induce antibodies during experimental Chagas' disease.
    Grögl M; Kuhn RE
    J Parasitol; 1985 Apr; 71(2):183-91. PubMed ID: 3923183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between autoantibodies arising during Trypanosoma cruzi infection in mice and natural autoantibodies.
    Ternynck T; Bleux C; Gregoire J; Avrameas S; Kanellopoulos-Langevin C
    J Immunol; 1990 Feb; 144(4):1504-11. PubMed ID: 2106000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic polymorphism of Trypanosoma cruzi: clonal analysis of trypomastigote surface antigens.
    Plata F; Garcia Pons F; Eisen H
    Eur J Immunol; 1984 May; 14(5):392-9. PubMed ID: 6373305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human and mouse sera recognize the same polypeptide associated with immunological resistance to Trypanosoma cruzi infection.
    Martins MS; Hudson L; Krettli AU; Cançado JR; Brener Z
    Clin Exp Immunol; 1985 Aug; 61(2):343-50. PubMed ID: 2412745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytophilic antibody in experimental Chagas' disease.
    Kuhn RE; Cassida GW
    J Parasitol; 1981 Dec; 67(6):807-12. PubMed ID: 6799634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous lytic activity against allogeneic tumor cells and depression of specific cytotoxic responses in mice infected with Trypanosoma cruzi.
    Hatcher FM; Kuhn RE
    J Immunol; 1981 Jun; 126(6):2436-42. PubMed ID: 6785354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of resistance against experimental Trypanosoma cruzi infection: the importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice.
    Kierszenbaum F; Howard JG
    J Immunol; 1976 May; 116(5):1208-11. PubMed ID: 818311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
    Umezawa ES; Shikanai-Yasuda MA; Stolf AM
    J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi: immunological consequences of parasite modification of host cells.
    Ribeiro Dos Santos R; Hudson L
    Clin Exp Immunol; 1980 Apr; 40(1):36-41. PubMed ID: 6771080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis.
    Krettli AU; Weisz-Carrington P; Nussenzweig RS
    Clin Exp Immunol; 1979 Sep; 37(3):416-23. PubMed ID: 116784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A; Sanchez G; Venegas J; Solari A
    Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi: immunity-induced in mice and rats by trypomastigote excretory-secretory antigens and identification of a peptide sequence containing a T cell epitope with protective activity.
    Taibi A; Plumas-Marty B; Guevara-Espinoza A; Schöneck R; Pessoa H; Loyens M; Piras R; Aguirre T; Gras-Masse H; Bossus M
    J Immunol; 1993 Sep; 151(5):2676-89. PubMed ID: 7689612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody with specificity for Trypanosoma cruzi, central and peripheral neurones and glia.
    Snary D; Flint JE; Wood JN; Scott MT; Chapman MD; Dodd J; Jessell TM; Miles MA
    Clin Exp Immunol; 1983 Dec; 54(3):617-24. PubMed ID: 6197220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of specific antibodies in Trypanosoma cruzi infections.
    Krettli AU; Brener Z
    J Immunol; 1976 Mar; 116(3):755-60. PubMed ID: 815433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.